(a) In Part V of this subtitle, the following words have the meanings indicated. (b) “Health care provider” means any licensed health care professional, organization, or institution, whether public or private, under whose authority pertussis vaccine is administered. (c) “Major adverse reaction” means: (1) Any serious illness, disability, or impairment of mental, emotional, behavioral, or physical functioning or development, […]
(a) (1) Prior to the administration of pertussis vaccine, the health care provider shall provide to the individual’s parent or guardian written information, satisfying the requirements of this subsection, and by appropriate inquiries attempt to elicit the information necessary to make the determinations required by § 18-332(b) of this subtitle. (2) The information required under paragraph (1) of […]
(a) At the time of administration of pertussis vaccine to an individual, the health care provider shall record in a permanent record to which the patient or the patient’s parent or guardian shall have access on request: (1) The date of each vaccination; (2) The manufacturer and lot number of the vaccine used for each; (3) Any other identifying […]
(a) By guideline, the Department shall establish a system, sufficient for the purposes of subsections (b) and (c) of this section, to collect data from the local health officers, from public and private health care providers, and from parents on the incidence of pertussis and major adverse reactions to pertussis vaccine. (b) On the basis of information […]
(a) The Department shall adopt guidelines, after notice and public hearing in accordance with the Administrative Procedure Act, setting forth: (1) The circumstances under which pertussis vaccine should not be administered; (2) The circumstances under which administration of the vaccine should be delayed; (3) Any categories of potential recipients who are significantly more vulnerable to major adverse reactions than […]